A detailed history of Israel Englander (Millennium Management LLC) transactions in Abbott Laboratories stock. As of the latest transaction made, Millennium Management LLC holds 1,110,500 shares of ABT stock, worth $129 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,110,500
Previous 2,328,311 52.3%
Holding current value
$129 Million
Previous $242 Million 47.67%
% of portfolio
0.06%
Previous 0.12%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$100.07 - $118.13 $105 Million - $125 Million
-1,053,977 Reduced 45.27%
1,274,334 $145 Million
Q2 2024

Aug 14, 2024

BUY
$100.73 - $112.44 $172 Million - $192 Million
1,708,782 Added 275.82%
2,328,311 $242 Million
Q1 2024

May 15, 2024

BUY
$109.52 - $120.96 $28.8 Million - $31.8 Million
263,010 Added 73.77%
619,529 $70.4 Million
Q4 2023

Feb 14, 2024

SELL
$90.19 - $110.4 $32.4 Million - $39.7 Million
-359,708 Reduced 50.22%
356,519 $39.2 Million
Q2 2023

Aug 14, 2023

SELL
$100.78 - $112.29 $10.6 Million - $11.9 Million
-105,576 Reduced 12.85%
716,227 $78.1 Million
Q1 2023

May 15, 2023

BUY
$96.86 - $114.01 $79.6 Million - $93.7 Million
821,803 New
821,803 $83.2 Million
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $129 Million - $149 Million
-1,334,413 Reduced 51.45%
1,259,182 $122 Million
Q2 2022

Aug 15, 2022

BUY
$102.07 - $123.37 $2.44 Million - $2.94 Million
23,869 Added 0.93%
2,593,595 $282 Million
Q1 2022

May 16, 2022

BUY
$114.02 - $139.04 $188 Million - $230 Million
1,650,980 Added 179.7%
2,569,726 $304 Million
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $30.8 Million - $37.8 Million
266,944 Added 40.95%
918,746 $129 Million
Q3 2021

Nov 15, 2021

SELL
$116.66 - $129.06 $49.7 Million - $55 Million
-426,093 Reduced 39.53%
651,802 $77 Million
Q2 2021

Aug 16, 2021

SELL
$105.79 - $124.53 $1.77 Million - $2.09 Million
-16,744 Reduced 1.53%
1,077,895 $125 Million
Q1 2021

May 17, 2021

SELL
$108.84 - $128.23 $39.2 Million - $46.2 Million
-360,528 Reduced 24.78%
1,094,639 $131 Million
Q4 2020

Feb 16, 2021

BUY
$105.0 - $114.42 $47.5 Million - $51.7 Million
451,970 Added 45.05%
1,455,167 $159 Million
Q3 2020

Nov 16, 2020

BUY
$91.64 - $111.29 $40 Million - $48.6 Million
436,277 Added 76.96%
1,003,197 $109 Million
Q2 2020

Aug 14, 2020

BUY
$76.57 - $98.0 $32.6 Million - $41.8 Million
426,168 Added 302.78%
566,920 $51.8 Million
Q1 2020

May 14, 2020

SELL
$62.82 - $91.86 $4.2 Million - $6.15 Million
-66,900 Reduced 32.22%
140,752 $11.1 Million
Q4 2019

Feb 14, 2020

SELL
$78.51 - $87.4 $5.3 Million - $5.9 Million
-67,462 Reduced 24.52%
207,652 $18 Million
Q3 2019

Nov 14, 2019

SELL
$81.84 - $88.74 $9.97 Million - $10.8 Million
-121,800 Reduced 30.69%
275,114 $23 Million
Q2 2019

Aug 14, 2019

BUY
$72.88 - $85.0 $28.3 Million - $33 Million
388,362 Added 4541.18%
396,914 $4.26 Million
Q2 2018

Aug 14, 2018

SELL
$57.57 - $63.54 $217 Million - $240 Million
-3,773,584 Reduced 99.77%
8,552 $522,000
Q1 2018

May 15, 2018

SELL
$56.27 - $63.62 $52.1 Million - $58.9 Million
-926,384 Reduced 19.67%
3,782,136 $227 Million
Q4 2017

Feb 14, 2018

BUY
$53.68 - $57.47 $251 Million - $269 Million
4,681,343 Added 17225.39%
4,708,520 $269 Million
Q3 2017

Nov 14, 2017

BUY
$48.06 - $53.64 $1.31 Million - $1.46 Million
27,177
27,177 $1.45 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.